1. Mahley RW, Rall SC. Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York, NY: McGraw-Hill; 1995. p. 1953–80.
2. Chuang TY, et al. Gestational hyperlipidemic pancreatitis caused by type III hyperlipoproteinemia with apolipoprotein E2/E2 homozygote. Pancreas. 2009;38:716–7.
3. Morganroth J, Levy RI, Fredrickson DS. The biochemical, clinical, and genetic features of type III hyperlipoproteinemia. Ann Int Med. 1975;82:158–74.
4. Murase T, Okubo M, Takeuchi I. Non-HDL cholesterol/apolipoprotein B ratio: a useful distinguishing feature in screening for type III hyperlipoproteinemia. J Clin Lipidol. 2010;4:99–104.
5. Zelis R, et al. Effects of hyperlipoproteinemias and their treatment on the peripheral circulation. J Clin Invest. 1970;49:1007–15.